Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Well that’s simply not true because pressure on Gilead has already made them agree to expire their exclusive rights to manufacture in the US by 2020.

It’s also not a rich vs poor country thing at all. It’s generic in almost all other parts of the world outside the US.



> generic in almost all other parts of the world outside the US.

in rich countries it s subsidized by generous healthcare contributions




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: